Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Cytomegalovirus and Effect on Early Chimerism in Patients with Myeloid Disorders Undergoing Stem Cell Transplantation Using Reduced Toxicity Ablative Conditioning Regimen

Shatha Y. Farhan, MD, George Divine, PhD, Klodiana Neme, PharmD, Danielle Pelland, Susan Wautelet, Nancy Mikulandric, PharmD, Kenneth Ruemenapp, Edward Peres, MD, Nalini Janakiraman, MD

Blood (2015) 126 (23): 5446.

https://doi.org/10.1182/blood.V126.23.5446.5446

Published: 2015

Journal Articles

Impact of Gender: Female Related Donor Versus Male Matched Unrelated Donor on Peripheral Blood Allogeneic Stem Cell Transplant for Male Recipients

Shatha Farhan, MD, Edward Peres, MD, Danielle Pelland, Susan Wautelet, Klodiana Neme, PharmD, Nancy Mikulandric, PharmD, Kenneth Ruemenapp, Mary Ann Trapp, Sarah Szymanski, Nalini Janakiraman, MD

Blood (2014) 124 (21): 5878.

https://doi.org/10.1182/blood.V124.21.5878.5878

Published: 2014

Journal Articles

High Rates of Early Donor Chimerism in Intermediate and Poor Risk Patients Undergoing Stem Cell Transplantation Using Reduced Toxicity Ablative Conditioning Regimen Incorporating Busulfan Pharmacokinetics

Shatha Farhan, MD, Edward Peres, MD, Danielle Pelland, Susan Wautelet, Klodiana Neme, PharmD, Nancy Mikulandric, PharmD, Kenneth Ruemenapp, Mary Ann Trapp, Sarah Szymanski, Nalini Janakiraman, MD

Blood (2014) 124 (21): 3874.

https://doi.org/10.1182/blood.V124.21.3874.3874

Published: 2014

Journal Articles

Frequency and Impact Of Allogeneic Hematopoetic Stem Cell Transplantation and Preparative Regimen In Patients With High and Intermediate Risk Acute Myeloid Leukemia: A Single Small Center Experience

Shatha Farhan, MD, Catherine Carroll, NP, Danielle Pelland, Jose Carlos Velasco, MD, Edward Peres, MD, Suseela M Janakiraman, MBBS, Susan Wautelet, Kenneth Ruemenapp, Philip Kuriakose, MD, Nalini Janakiraman, MD

Blood (2013) 122 (21): 5550.

https://doi.org/10.1182/blood.V122.21.5550.5550

Published: 2013

Journal Articles

Impact Of Dysplasia On Outcome Of Patients With Acute Myeloid Leukemia and Response To Allogeneic Hematopoetic Stem Cell Transplantation

Shatha Farhan, MD, Catherine Carroll, NP, Danielle Pelland, Jose Carlos Velasco, MD, Susan Wautelet, Kenneth Ruemenapp, Suseela M Janakiraman, MBBS, Philip Kuriakose, MD, Edward Peres, MD, Nalini Janakiraman, MD

Blood (2013) 122 (21): 5551.

https://doi.org/10.1182/blood.V122.21.5551.5551

Published: 2013

NARROW

Cytomegalovirus and Effect on Early Chimerism in Patients with Myeloid Disorders Undergoing Stem Cell Transplantation Using Reduced Toxicity Ablative Conditioning Regimen

Impact of Gender: Female Related Donor Versus Male Matched Unrelated Donor on Peripheral Blood Allogeneic Stem Cell Transplant for Male Recipients

High Rates of Early Donor Chimerism in Intermediate and Poor Risk Patients Undergoing Stem Cell Transplantation Using Reduced Toxicity Ablative Conditioning Regimen Incorporating Busulfan Pharmacokinetics

Frequency and Impact Of Allogeneic Hematopoetic Stem Cell Transplantation and Preparative Regimen In Patients With High and Intermediate Risk Acute Myeloid Leukemia: A Single Small Center Experience

Impact Of Dysplasia On Outcome Of Patients With Acute Myeloid Leukemia and Response To Allogeneic Hematopoetic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Cytomegalovirus and Effect on Early Chimerism in Patients with Myeloid Disorders Undergoing Stem Cell Transplantation Using Reduced Toxicity Ablative Conditioning Regimen

Impact of Gender: Female Related Donor Versus Male Matched Unrelated Donor on Peripheral Blood Allogeneic Stem Cell Transplant for Male Recipients

High Rates of Early Donor Chimerism in Intermediate and Poor Risk Patients Undergoing Stem Cell Transplantation Using Reduced Toxicity Ablative Conditioning Regimen Incorporating Busulfan Pharmacokinetics

Frequency and Impact Of Allogeneic Hematopoetic Stem Cell Transplantation and Preparative Regimen In Patients With High and Intermediate Risk Acute Myeloid Leukemia: A Single Small Center Experience

Impact Of Dysplasia On Outcome Of Patients With Acute Myeloid Leukemia and Response To Allogeneic Hematopoetic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only